No Data
Earnings Preview: PAVmed to Report Financial Results Pre-market on November 14
$PAVmed(PAVM.US)$ is scheduled to release its financial results pre-market on November 14 ET. Earnings PreviewAnalysts estimate $PAVmed(PAVM.US)$ to post revenue of USD1.09M for 2024Q3, up 38.22% YOY;
Express News | Lucid Diagnostics' Esoguard Be-1 Prospective Multicenter Clinical Validation Study of Esoguard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard Esophageal Precancer Testing Accepted for Peer-Reviewed Publication
Press Release: Lucid Diagnostics Expands Direct Contracting Initiative With Multiple Programs Focused on Near-Term Revenue Drivers
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 13, 2024
Express News | Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its Esoguard Esophageal DNA Test
No Data
No Data